BTAI
BioXcel Therapeutics, Inc.
+0.02 (+49.66%)0.07USD1.1M成交股數2.1M市值–本益比(近四季)2.8股價營收比+51.7%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 182K+52% | 206K+23% | 256K+20% | 98K-91% | 120K-79% | 168K-55% | 214K-37% | 1.1M+142% | 582K | 376K | 341K | 457K |
| 營業成本 | 22K | 283K | 32K | 11K | 107K | 14K | 1.2M | 62K | 80K | 713K | 512K | 26K |
| 毛利 | 160K+1131% | −77K-150% | 224K-123% | 87K-92% | 13K-97% | 154K-146% | −956K+459% | 1.0M+142% | 502K | −337K | −171K | 431K |
| 毛利率 | 87.9% | -37.4% | 87.5% | 88.8% | 10.8% | 91.7% | -446.7% | 94.4% | 86.3% | -89.6% | -50.1% | 94.3% |
| 研發費用 | 3.2M | 3.0M | 6.7M | 8.7M | 10.3M | 4.6M | 5.1M | 8.0M | 11.4M | 9.9M | 19.6M | 27.0M |
| 銷售管理費用 | 7.2M | 7.2M | 3.8M | 5.4M | 5.6M | 5.7M | 7.7M | 9.5M | 13.3M | 9.6M | 24.3M | 25.9M |
| 營業利益 | −10.2M-36% | −10.2M+1% | −10.3M-33% | −14.2M-18% | −15.9M-34% | −10.1M-49% | −15.3M-68% | −17.3M-67% | −24.2M | −19.9M | −48.3M | −52.4M |
| 營業利益率 | -5,600.5% | -4,962.6% | -4,016.4% | -14,518.4% | -13,210.0% | -6,011.3% | -7,146.3% | -1,566.7% | -4,151.7% | -5,285.4% | -14,163.3% | -11,469.1% |
| 稅後淨利 | −14.7M-23% | −12.7M+75% | −12.5M-8% | −30.9M+272% | −19.2M-28% | −7.3M-67% | −13.7M-73% | −8.3M-84% | −26.8M | −22.3M | −50.5M | −53.5M |
| 淨利率 | -8,084.1% | -6,160.7% | -4,900.4% | -31,541.8% | -15,989.2% | -4,317.9% | -6,378.5% | -751.7% | -4,603.3% | -5,919.1% | -14,805.3% | -11,710.1% |
| 稀釋 EPS | -0.49-80% | -0.54-64% | 0.40-108% | -2.18-34% | -2.45-82% | -1.50-98% | -5.15+199% | -3.30+80% | -13.89 | -92.94 | -1.72 | -1.83 |
| 稀釋股數 | 30.3M | 23.6M | 12.2M | 14.2M | 7.8M | 4.8M | 2.6M | 2.5M | 1.9M | 1.8M | 29.3M | 29.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 12.8M | 17.2M | 28.4M | 36.2M | 17.4M | 31.0M | 40.4M | 56.3M | 74.1M | 65.2M | 90.0M | 128M |
| 應收帳款 | 82K | 216K | 233K | 0 | 17K | – | 3K | 812K | 378K | 71K | 735K | 431K |
| 存貨 | 483K | 500K | 722K | 459K | 506K | 642K | 1.5M | 2.7M | 2.4M | 2.0M | 2.0M | 1.9M |
| 總資產 | 28.8M | 34.0M | 44.9M | 44.8M | 25.8M | 38.6M | 48.9M | 65.4M | 82.3M | 73.7M | 100M | 140M |
| 有息負債 | 0 | 77.9M | 84.7M | 92.3M | 97.5M | 99.9M | 104M | 103M | 102M | 101M | 99.1M | 96.8M |
| 總負債 | 144M | 140M | 140M | 134M | 133M | 129M | 135M | 140M | 155M | 130M | 141M | 134M |
| 股東權益 | −115M | −106M | −95.5M | −88.9M | −108M | −90.2M | −85.6M | −74.3M | −72.4M | −56.5M | −40.6M | 5.9M |
| 負債比 | 500.9% | 410.2% | 312.5% | 298.5% | 517.5% | 333.8% | 275.1% | 213.5% | 187.9% | 176.7% | 140.4% | 95.8% |
| 淨現金(現金 − 有息負債) | 12.8M | −60.7M | −56.2M | −56.1M | −80.0M | −68.9M | −64.1M | −46.7M | −27.5M | −35.4M | −9.1M | 30.7M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −11.8M-2% | – | – | – | −12.0M | – | – | −17.7M | – | – | – |
| 資本支出 | – | 0 | – | – | – | 0 | – | – | – | – | – | – |
| 自由現金流 | – | −11.8M-2% | – | – | – | −12.0M | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -5,732.5% | – | – | – | -7,168.5% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 642K
| Single Reportable | 642K | 100.0% | -71.7% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 642K | -71.7% | −69.9M | -10,887.4% | -5.73 | −57.6M |
| FY2024 | 2.3M | +64.2% | −59.6M | -2,630.1% | -23.51 | −72.0M |
| FY2023 | 1.4M | +268.0% | −179M | -12,974.9% | -98.33 | −155M |
| FY2022 | 375K | – | −166M | -44,201.9% | -5.92 | −135M |
| FY2021 | – | – | −107M | –% | -4.05 | −82.6M |
| FY2020 | – | – | −82.2M | –% | -3.79 | −66.7M |
| FY2019 | – | – | −33.0M | –% | -2.02 | −28.0M |
| FY2018 | – | – | −19.3M | –% | -1.32 | −13.8M |